T38.905
Adverse effect of unspecified hormone antagonists
Clinical Classification Guidelines
Medical Intelligence & Overview
The ICD-10 code T38.905 pertains to adverse effects caused by unspecified hormone antagonists. Hormone antagonists are medications that block or inhibit the effects of hormones in the body and are commonly used in treating various conditions such as hormone-sensitive cancers, hormonal imbalances, and other medical issues. While these medications can be highly effective, they may sometimes lead to undesirable side effects or adverse reactions. Recognizing these adverse effects is important for managing treatment and ensuring patient safety.
Causes & Symptoms
Clinical Causes: Use of hormone antagonists like tamoxifen, flutamide, or bicalutamide without specific identification Incorrect dosage or prolonged use of hormone antagonist medications Patient-specific reactions such as allergies or sensitivities Drug interactions with other medications that enhance adverse effects Underlying medical conditions that increase susceptibility to side effects
Key Symptoms: Hot flashes or night sweats Mood swings or depression Nausea or vomiting Fatigue or weakness Breast tenderness or pain Muscle or joint pain Changes in menstrual cycle or irregular bleeding Bone or joint discomfort Liver function abnormalities Fluid retention or swelling Altered lipid profile or cholesterol levels Skin rashes or allergic skin reactions
Diagnostic & Treatment
Diagnosis Path: Diagnosing adverse effects of hormone antagonists involves a thorough clinical evaluation, including a detailed medical history and medication review. Blood tests may be performed to assess liver function, hormonal levels, and other relevant parameters. Imaging studies or additional laboratory assessments can help exclude other possible causes of symptoms. Healthcare professionals may also monitor for known side effects associated with specific hormone antagonists used in the patient's treatment regimen.
Treatment Protocols: Management of adverse effects from hormone antagonists focuses on symptom relief and adjusting therapy when necessary. Strategies include:
Clinical Advice & FAQs
Billing Guidance
Is T38.905 a billable ICD-10 code?
Yes, T38.905 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T38.905?
Clinical documentation must specify the nature of Adverse effect of unspecified hormone antagonists and any associated comorbidities for accurate reporting.
Cite this Clinical Reference